📈 Jumpstart Signal Watchlist — June 11, 2026

🏢 What they do: Pitney Bowes is a technology-driven shipping, mailing, and financial services company. It provides tools and services such as postage meters, mailing equipment, shipping software, presort mail services, and parcel/shipping management solutions for businesses of all sizes.
- 🎯 At/above 3yr high $17.14 (current $17.14) · ⏳ SMA200 $11.64 (current price $17.14 is above) · 💰 Market Cap $3.4B
- PBI shows decent technicals supported by positive sentiment.

💎 Quality (Q): 44/60
- 🏦 Low drawdown (11.9% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 105% (>20%); PEG ratio 0.16 (<1.5).
⏰ Entry (E): 2/20
- 🔔 Strong above EMA21 (6.6%)
- 🔔 Strong above EMA50 (16.0%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 69 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Pitney Bowes (NYSE:PBI) Hits New 1-Year High - Should You Buy? — MarketBeat.
🤖 The article says PBI hit a new 52-week high and notes stronger analyst tone, including a Bank of America upgrade to neutral and a Moderate Buy consensus. That combination of price strength and improving sentiment is positive for the stock.
✅ Pitney Bowes stock hits 52-week high at 17.13 USD — Investing.com.
🤖 This report highlights that PBI reached a new 52-week high, signaling strong recent momentum in the shares. A breakout to a fresh high is generally positive for near-term stock sentiment.
🍭 Bonus (B): 0/10 — Office Machines

🏢 What they do: Alto Ingredients, Inc. produces and distributes specialty alcohols, renewable fuels, and essential ingredients. Its products include alcohols used in items like mouthwash, cosmetics, pharmaceuticals, and cleaners, as well as fuel-grade ethanol, yeast, feed ingredients, and other corn-based co-products for food, beverage, animal feed, and industrial uses.
- 🎯 Current $5.65 is 6% below 3yr high $5.99 · ⏳ SMA200 $2.91 (current price $5.65 is above) · 💰 Market Cap $440M
- ALTO passed all filters and shows favorable conditions.

💎 Quality (Q): 45/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 131% (>20%); Low LT D/E 0.31 (<1.0); PEG ratio 0.12 (<1.5).
⏰ Entry (E): 6/20
- 🔔 Strong above EMA21 (7.6%)
- 🔔 Strong above EMA50 (15.3%)
- 🔔 SMA20/SMA50 bullish crossover
- 📈 RSI at 61 showing strength
- ⚠️ SMA20/SMA50 bearish crossover
📢 Sentiment (S): 5/10
- 🗞️ News sentiment is neutral.
⚪️ House lawmakers pass year-round nationwide sales of higher ethanol gasoline — Seeking Alpha.
🤖 The article is industry-relevant because higher nationwide E15 sales could support ethanol demand, which may be indirectly beneficial to Alto Ingredients. However, it is a policy story rather than company-specific news and does not report direct operational or financial results for $ALTO.
🍭 Bonus (B): 0/10 — Industrial Organic Chemicals

🏢 What they do: Exelixis is an oncology-focused biotechnology company that discovers, develops, and commercializes medicines for hard-to-treat cancers. Its main products include CABOMETYX (cabozantinib), COMETRIQ (cabozantinib), and COTELLIC (cobimetinib), and it also advances a pipeline of small molecules and biotherapeutics for cancer treatment.
- 🎯 At/above 3yr high $53.50 (current $53.50) · ⏳ SMA200 $42.98 (current price $53.50 is above) · 💰 Market Cap $13.6B
- EXEL shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (12.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 44% (>20%); ROE 43% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 2/20
- 🔔 Strong above EMA21 (6.4%)
- 🔔 Strong above EMA50 (11.5%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 64 showing strength
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive.
✅ Goldman Sachs Group Inc. Purchases 1,113,916 Shares of Exelixis ... — MarketBeat.
🤖 This is mildly positive because it reports a large increase in Goldman Sachs’ stake in Exelixis, which can be read as institutional confidence. The article also notes EXEL trading near its 52-week high and references strong recent earnings.
✅ Exelixis, Inc. $EXEL Position Increased by Northwestern Mutual Wealth Management Co. — MarketBeat.
🤖 This is positive because it highlights another institutional investor increasing its holdings in Exelixis. The article also frames the stock as trading near its 52-week high, which supports a constructive near-term sentiment.
⚪️ Geode Capital Management LLC Sells 141,796 Shares of Exelixis ... — MarketBeat.
🤖 This is mixed to neutral: the headline is about a stake reduction, but the article also emphasizes Exelixis’ earnings beat and revenue growth. The offsetting signals make the overall stock impact less directional.
⚪️ Exelixis, Inc. (EXEL) Earnings Dates & Report - Seeking Alpha — Seeking Alpha.
🤖 This is neutral because it mainly reports already-published earnings results rather than introducing new stock-moving information. It confirms the company beat EPS and revenue expectations, but the article itself is mostly an earnings summary.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: Amkor Technology, Inc. (AMKR) is the world's largest U.S.-headquartered outsourced semiconductor assembly and test (OSAT) provider, specializing in semiconductor packaging and test services.
- 🎯 Current $76.15 is 2% below 3yr high $78.10 · ⏳ SMA200 $45.80 (current price $76.15 is above) · 💰 Market Cap $18.9B
- AMKR shows decent technicals supported by positive sentiment.

💎 Quality (Q): 49/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 267% (>20%); Revenue growth 27% (>15%); Low LT D/E 0.25 (<1.0); PEG ratio 0.16 (<1.5).
⏰ Entry (E): 2/20
- 🔔 Strong above EMA21 (7.5%)
- 🔔 Strong above EMA50 (14.6%)
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Amkor Technology Targets $11B Revenue by 2030 on AI Packaging, Arizona Ramp — MarketBeat.
🤖 This article highlights Amkor's long-term growth targets, including revenue above $11 billion by 2030 and margin expansion driven by advanced packaging and Arizona capacity ramp-up. Those goals suggest stronger future earnings potential and are generally constructive for the stock.
🍭 Bonus (B): 10/10 — Semiconductors (Technology sector)

🏢 What they do: Hewlett Packard Enterprise (HPE) is an enterprise technology company that provides compute, storage, networking, and software solutions designed for hybrid IT environments and AI infrastructure.
- 🎯 Current $46.80 is 17% below 3yr high $56.15 · ⏳ SMA200 $25.41 (current price $46.80 is above) · 💰 Market Cap $61.9B
- HPE shows decent technicals supported by positive sentiment.

💎 Quality (Q): 47/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 154% (>20%); Revenue growth 40% (>15%); Low LT D/E 0.86 (<1.0); PEG ratio 0.28 (<1.5).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (11.0%)
- 🔔 Strong above EMA50 (33.3%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 63 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Hewlett Packard Enterprise (NYSE:HPE) Price Target Raised to ... — MarketBeat.
🤖 Citigroup raised its price target on HPE from $39 to $70 and kept a buy rating, signaling greater upside expectations for the stock. The article also says HPE jumped after reporting strong quarterly results with EPS and revenue well above estimates.
✅ What To Do After Dell's Breakout Boosted Hewlett-Packard ... — Seeking Alpha.
🤖 The article frames HPE as benefiting from Dell's strong earnings and analyst upgrades, highlighting favorable sentiment around AI and server demand. It cites Citi and JPMorgan as part of the supportive analyst backdrop for HPE.
🍭 Bonus (B): 10/10 — Computer & Office Equipment (Technology sector)

🏢 What they do: OneSpaWorld Holdings Limited provides health, wellness, spa, fitness, and beauty services and products, primarily on cruise ships and at destination resorts. It operates spa and wellness programs for guests at sea and on land, including treatments, retail products, and related spa services.
- 🎯 Current $24.81 is 2% below 3yr high $25.32 · ⏳ SMA200 $21.92 (current price $24.81 is above) · 💰 Market Cap $1.5B
- OSW shows decent technicals supported by positive sentiment.

💎 Quality (Q): 51/60
- 🏦 Low drawdown (12.9% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 40% (>20%); Low LT D/E 0.15 (<1.0); PEG ratio 0.83 (<1.5).
⏰ Entry (E): 4/20
- ⚠️ SMA20/SMA50 bearish crossover
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Truist raises OneSpaWorld stock price target on wellness trends — Investing.com.
🤖 Truist increased its estimate for 2026 Adjusted EBITDA to $137.9 million, signaling improved operating expectations for OSW. A higher price target tied to wellness trends is generally supportive for the stock.
✅ OneSpaWorld Stock: All Aboard! (NASDAQ:OSW) — Seeking Alpha.
🤖 This article highlights OneSpaWorld's dominant market position and cites 2026 revenue guidance of about $1.014 billion to $1.034 billion. The commentary and forward revenue outlook are favorable for OSW.
🍭 Bonus (B): 0/10 — Membership Sports & Recreation

🏢 What they do: Pediatrix Medical Group, Inc. (ticker: MD) is one of the nation's largest providers of physician-led prenatal, neonatal, maternal-fetal, and pediatric subspecialty services. The company partners with nearly 400 hospitals across 36 states, staffing NICUs and delivering coordinated, evidence-based care to women, babies, and children through a network of over 4,400 affiliated clinicians.
- 🎯 Current $24.16 is 2% below 3yr high $24.65 · ⏳ SMA200 $20.53 (current price $24.16 is above) · 💰 Market Cap $2.0B
- MD shows decent technicals supported by positive sentiment.

💎 Quality (Q): 51/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 50% (>20%); ROE 20% (>15%); Low LT D/E 0.70 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 4/20
- 🔔 Strong above EMA21 (8.0%)
- 📈 RSI at 67 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Pediatrix Medical Group (MD) Q1 2026 Earnings: EPS Beats Estimates by Nearly 13% as Stock Declines 20.773 — ProductSafetyLetter.
🤖 Pediatrix Medical Group reported Q1 2026 EPS of $0.44, beating the consensus estimate of $0.3898 by 12.88%. An earnings beat is generally positive for the stock, even though the article notes the shares declined afterward.
✅ Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock — Zacks.
🤖 Zacks describes Pediatrix Medical Group as a strong growth stock, which is a favorable signal for investor sentiment. The article is broadly constructive rather than reporting a negative company-specific event.
🍭 Bonus (B): 0/10 — Hospitals